0

Mefenamic acid

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAPS61687
CAS61-68-7
Structure
MDL NumberMFCD00051721
SynonymsRelafan, 2-(2,3-Dimethylanilino)benzoic acid, Coslan, C.I. 473, 2-[(2,3-Dimethylphenyl)amino]benzoic acid, Bafameritin M, Mefenacid, N-(2,3-Xylyl)-2-aminobenzoic acid, In-M, Mephenamic acid, Mefenamic acid, N-(2,3-Xylyl)anthranilic acid, Tanston, Baphameritin M, INF 3355,Mefenamic Acid, Namphen, Ponalar, Ponstan, Vialidon, Bonabol, 2',3'-Dimethyl-N-phenylanthranilic acid, Ponstyl, Pontal, N-(2,3-Dimethylphenyl)anthranilic acid, NSC 94437, Ponstil, CN 35355, Ponstel, Parkemed, Mefacit, Lysalgo, Anthranilic acid, N-2,3-xylyl- (8CI)
IUPAC Name2-(2,3-dimethylanilino)benzoic acid
Molecular Weight241.29
Molecular FormulaC15H15NO2
Canonical SMILESCc1cccc(Nc2ccccc2C(=O)O)c1C
InChIInChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)
InChI KeyHYYBABOKPJLUIN-UHFFFAOYSA-N
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Accurate Mass241.1103
FormatNeat
Size200MG
  • Verification code
CATSizeShippingStorage ConditionsDescription
APS61687-1 250MG Room Temperature +20°C Subcategory: EU Methods, Pharmaceutical and veterinary compounds and metabolites Inquiry
APS61687-2 50MG Room Temperature 2-8°C Fridge/Coldroom API Family: Matrix - API Family See respective official monograph(s); Product Type: API; Subcategory: European Pharmacopoeia (Ph. Eur.) Inquiry
APS61687-3 250MG Room Temperature +5°C API Family: Matrix - API Family Mefenamic Acid; Product Type: API; Subcategory: Mikromol, Analgesics, API standards, Non-steroidal anti-inflammatory drugs (NSAIDs) Inquiry
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode
Privacy Policy | Cookie Policy | Copyright © 2024 Alfa Chemistry. All rights reserved.